Small Cell Lung Carcinoma
"Small Cell Lung Carcinoma" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A form of highly malignant lung cancer that is composed of small ovoid cells (SMALL CELL CARCINOMA).
Descriptor ID |
D055752
|
MeSH Number(s) |
C04.588.894.797.520.109.220.624 C08.381.540.140.750 C08.785.520.100.220.750
|
Concept/Terms |
Small Cell Lung Carcinoma- Small Cell Lung Carcinoma
- Small Cell Lung Cancer
- Oat Cell Lung Cancer
- Small Cell Cancer Of The Lung
- Carcinoma, Small Cell Lung
- Oat Cell Carcinoma of Lung
|
Below are MeSH descriptors whose meaning is more general than "Small Cell Lung Carcinoma".
Below are MeSH descriptors whose meaning is more specific than "Small Cell Lung Carcinoma".
This graph shows the total number of publications written about "Small Cell Lung Carcinoma" by people in this website by year, and whether "Small Cell Lung Carcinoma" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2011 | 2 | 0 | 2 |
2015 | 1 | 0 | 1 |
2017 | 12 | 2 | 14 |
2018 | 20 | 1 | 21 |
2019 | 5 | 0 | 5 |
2020 | 2 | 0 | 2 |
2021 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Small Cell Lung Carcinoma" by people in Profiles.
-
Severity of COVID-19 in patients with lung cancer: evidence and challenges. J Immunother Cancer. 2021 03; 9(3).
-
Changes in Lung Cancer Treatment as a Result of the Coronavirus Disease 2019 Pandemic. JAMA Oncol. 2020 11 01; 6(11):1805-1806.
-
Collateral effects of the coronavirus disease 2019 pandemic on lung cancer diagnosis in Korea. BMC Cancer. 2020 Oct 29; 20(1):1040.
-
The impact of the COVID-19 pandemic on lung cancer patients. Ann Palliat Med. 2020 Sep; 9(5):3373-3378.
-
Consensus statement: summary of the Quebec Lung Cancer Network recommendations for prioritizing patients with thoracic cancers in the context of the COVID-19 pandemic. Curr Oncol. 2020 06; 27(3):e313-e317.
-
ESMO Management and treatment adapted recommendations in the COVID-19 era: Lung cancer. ESMO Open. 2020 06; 5(Suppl 3).
-
Optimizing lung cancer radiation treatment worldwide in COVID-19 outbreak. Lung Cancer. 2020 08; 146:230-235.
-
Cancer in the time of COVID-19: expert opinion on how to adapt current practice. Eur Respir J. 2020 05; 55(5).
-
Reduced Fractionation in Lung Cancer Patients Treated with Curative-intent Radiotherapy during the COVID-19 Pandemic. Clin Oncol (R Coll Radiol). 2020 08; 32(8):481-489.
-
A favorable outcome of pneumonia COVID 19 in an advanced lung cancer patient with severe neutropenia: Is immunosuppression a risk factor for SARS-COV2 infection? Lung Cancer. 2020 07; 145:213-215.